Joseph S McCracken Insider Trading $NVET Nexvet Biopharma plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joseph S McCracken.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joseph S McCracken. Joseph S McCracken is Director in Savara Inc ($MSTX) and Director in LUMOS PHARMA, INC. ($NLNK) and Director in Kindred Biosciences, Inc. ($KIN) and Director in Nexvet Biopharma plc ($NVET).
Joseph S McCracken in Nexvet Biopharma plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joseph S McCracken: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 02 2017
$NVET Market Capitalization: $40.45M
$NVET Previous Close: $3.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Joseph S McCracken in Nexvet Biopharma plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, KIN, NLNK, NVET, SVRA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Sell | D | 6.72 | 16,400 | 110,208 | 0 | 16.4 K to 0 (-100.00 %) |
| Jul 05 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 3,600 | 450 | 0 | |
| Jul 05 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 0 | |
| Jul 05 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 3,600 | 450 | 16,400 | 12.8 K to 16.4 K (+28.13 %) |
| Jul 05 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 12,800 | 12.3 K to 12.8 K (+4.07 %) |
| Apr 04 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 500 | |
| Apr 04 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 12,300 | 11.8 K to 12.3 K (+4.24 %) |
| Jan 03 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 1,000 | |
| Jan 03 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 11,800 | 11.3 K to 11.8 K (+4.42 %) |
| Oct 04 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 1,500 | |
| Oct 04 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 11,300 | 10.8 K to 11.3 K (+4.63 %) |
| Sep 07 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 3,600 | 450 | 3,600 | |
| Jul 01 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 3,600 | 450 | 0 | |
| Jul 01 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 2,000 | |
| Jul 01 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 3,600 | 450 | 10,800 | 7.2 K to 10.8 K (+50.00 %) |
| Jul 01 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 7,200 | 6.7 K to 7.2 K (+7.46 %) |
| Apr 04 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 2,500 | |
| Apr 04 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 6,700 | 6.2 K to 6.7 K (+8.06 %) |
| Jan 05 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 3,000 | |
| Jan 05 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 6,200 | 5.7 K to 6.2 K (+8.77 %) |
| Oct 01 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 3,500 | |
| Oct 01 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 5,700 | 5.2 K to 5.7 K (+9.62 %) |
| Sep 08 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | A | 0.13 | 3,600 | 450 | 3,600 | |
| Jul 02 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 4,000 | |
| Jul 02 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 900 | 113 | 0 | |
| Jul 02 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 5,200 | 4.7 K to 5.2 K (+10.64 %) |
| Jul 02 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 900 | 113 | 4,700 | 3.8 K to 4.7 K (+23.68 %) |
| May 20 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 4,500 | |
| May 20 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 900 | 113 | 900 | |
| May 20 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 1,400 | 175 | 3,800 | 2.4 K to 3.8 K (+58.33 %) |
Page: 1